000			02470nam a22002897a 4500
003			OSt
005			20240305193742.0
008			221201b |||||||| |||| 00| 0 eng d
028			_b Phone: +255 28 298 3384
028			_b Fax: +255 28 298 3386
028			_b Email: vc@bugando.ac.tz
028			_b Website: www.bugando.ac.tz
040			_bEnglish _cDLC
041			_aEnglish
100			_aAlphonce B Chandika _923222
222			_a Breast abscess Ultrasound guided needle aspiration Surgical drainage Uganda
245			_aUltrasound Guided Needle Aspiration versus Surgical Drainage in the management of breast abscesses: a Ugandan experience
260			_aMwanza, Tanzania: _bBioMed Central & _bCatholic University of Health and Allied Sciences [CUHAS – Bugando] _c06 January 2012
300			_aPages 1-7
490			_vBMC research notes Volume 5 Issue 1
520			_aAbstract: Background: Despite breast abscess becoming less common in developed countries, it has remained one of the leading causes of morbidity in women in developing countries. A randomized controlled trial was conducted at Mulago hospital complex in Kampala Uganda to establish whether ultrasound guided needle aspiration is a feasible alternative treatment option for breast abscesses. Results: A total of 65 females with breast abscess were analyzed, of these 33 patients were randomized into the ultrasound guided needle aspiration and 32 patients in the Incision and drainage arm. The mean age was 23.12, most of them were lactating (66.2%), primipararous (44.6%) with peripheral abscesses (73.8%) located in the upper lateral quadrant (56%).The mean breast size was 3.49 cm. The two groups were comparably in demographic characteristic and breast abscess size. Survival analysis showed no difference in breast abscess healing rate between the two groups (Log rank 0.24 df 1 and P = 0.63). Incision and drainage was found to be more costly than ultrasound guided aspiration (cost effective ratio of 2.85). Conclusion: Ultrasound guided needle aspiration is therefore a feasible and cost effective treatment option for both lactating and non lactating breast abscesses with a diameter up to 5 cm by ultrasound in an immune competent patient
700			_a Anthony M Gakwaya _946451
700			_aElsie Kiguli-Malwadde _946452
700			_a Phillipo L Chalya _915821
856			_uhttps://doi.org/10.1186/1756-0500-5-12
942			_2ddc _cVM
999			_c19841 _d19841